165 related articles for article (PubMed ID: 3784403)
1. [Cancer of the prostate with metastases to the bone marrow].
Tachev S; Ormanov I; Slavov Ch
Khirurgiia (Sofiia); 1986; 39(5):96-7. PubMed ID: 3784403
[No Abstract] [Full Text] [Related]
2. [Hematologic manifestations of cancers of the prostate].
Piot G; Finaud M; Bayle C; Subtil E; Droz JP
J Urol (Paris); 1985; 91(9):617-22. PubMed ID: 3834002
[TBL] [Abstract][Full Text] [Related]
3. Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells.
Haq M; Goltzman D; Tremblay G; Brodt P
Cancer Res; 1992 Sep; 52(17):4613-9. PubMed ID: 1511429
[TBL] [Abstract][Full Text] [Related]
4. [Morphological and histomorphometric study of bone and bone marrow metastases of prostatic adenocarcinoma].
Cambon C; Pinel B; Le Loët X; Tayot J; Basuyau JP; Deshayes P
Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):643-50. PubMed ID: 6523015
[No Abstract] [Full Text] [Related]
5. Challenging problems in advanced malignancy: Case 2. Disseminated intravascular coagulation in metastatic hormone-refractory prostate cancer.
Kampel LJ
J Clin Oncol; 2003 Aug; 21(16):3170-1. PubMed ID: 12915609
[No Abstract] [Full Text] [Related]
6. [Clinical study on prostate cancer initially presenting with disseminated intravascular coagulation syndrome].
Ohtake N; Kurita S; Fukabori Y; Imai K; Yamanaka H; Nakata S; Sato J; Kurihara J; Mashimo M; Sekihara T; Saruki K; Kawashima K; Takahashi H; Tsuchiya K; Okabe K; Jimbo S; Kurita M
Hinyokika Kiyo; 1998 Jun; 44(6):387-90. PubMed ID: 9719936
[TBL] [Abstract][Full Text] [Related]
7. A case of extremely advanced prostate cancer presenting hemolytic jaundice.
Wakisaka M; Takagishi H
Hinyokika Kiyo; 1994 Mar; 40(3):261-3. PubMed ID: 8178748
[TBL] [Abstract][Full Text] [Related]
8. Does bladder neck carcinoma exhibit the same propensity for osseous metastases as prostatic carcinoma? (A comparative bone marrow cytological study).
Nawaz SK; Rao MS; Bapna BC; Das KC; Gupta S; Vaidyanathan S; Jain S
Indian J Cancer; 1979 Jun; 16(2):50-3. PubMed ID: 546731
[No Abstract] [Full Text] [Related]
9. Trousseau's syndrome in a patient with metastatic prostate cancer.
Rodriguez R; Walsh PC
J Urol; 2000 Jun; 163(6):1877. PubMed ID: 10799213
[No Abstract] [Full Text] [Related]
10. A patient with prostate cancer and multiple myeloma-diagnostics and possible association of both diseases.
Sučić M; Bišof V; Cačić M; Kinda SB; Kolenc D; Ljubić N; Sučić T; Potočki K
Ann Diagn Pathol; 2012 Dec; 16(6):515-20. PubMed ID: 21840230
[TBL] [Abstract][Full Text] [Related]
11. The hemophagocytic syndrome in prostate cancer revealed by disseminated carcinomatosis of the bone marrow.
Koizumi K; Haseyama Y; Machino R; Sato Y; Sawada K; Koike T
J Urol; 2002 Sep; 168(3):1101-2. PubMed ID: 12187236
[No Abstract] [Full Text] [Related]
12. Ketoconazole-induced adrenal crisis in a patient with metastatic prostatic adenocarcinoma: case report and review of the literature.
Sarver RG; Dalkin BL; Ahmann FR
Urology; 1997 May; 49(5):781-5. PubMed ID: 9145992
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of DCE-MRI postprocessing techniques to assess metastatic bone marrow in patients with prostate cancer.
Michoux N; Simoni P; Tombal B; Peeters F; Machiels JP; Lecouvet F
Clin Imaging; 2012; 36(4):308-15. PubMed ID: 22726969
[TBL] [Abstract][Full Text] [Related]
14. Primary hyperfibrinolysis as the presenting sign of prostate cancer: A case report.
Kulić A; Cvetković Z; Libek V
Vojnosanit Pregl; 2016 Sep; 73(9):877-80. PubMed ID: 29320623
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow necrosis by diffuse metastatic intravascular obstruction.
Ricci P; Bandini G; Baccarani M; Bazzocchi F; Martinelli G; Tura S
Haematologica; 1982 Oct; 67(5):754-9. PubMed ID: 6816686
[No Abstract] [Full Text] [Related]
16. Bone metastases from prostate cancer without elevated prostate-specific antigen levels: diagnosis by anti-PSA immunostaining.
Berthelot JM; Gouin F; Denis M; Nomballais MF; Maugars Y; Blaive-Cervi S; Prost A
Rev Rhum Engl Ed; 1995 Jan; 62(1):54-5. PubMed ID: 7540487
[No Abstract] [Full Text] [Related]
17. The if's, and's, or but's regarding bisphosphonates for prostate cancer.
Wilt TJ; Ensrud KE
J Natl Cancer Inst; 2007 May; 99(10):744-5. PubMed ID: 17505065
[No Abstract] [Full Text] [Related]
18. [Bone and bone marrow metastases of prostatic adenocarcinoma: the serum level of prostate-specific antigen may be normal].
Marlier S; Durupt S; de Jaureguiberry JP; Marlier-Civatte M; Peybere B; Jaubert D
Presse Med; 1996 May 4-11; 25(16):777. PubMed ID: 8692758
[No Abstract] [Full Text] [Related]
19. Disseminated intravascular coagulation in a patient with metastatic prostate cancer: fatal outcome following strontium-89 therapy.
Leong C; McKenzie MR; Coupland DB; Gascoyne RD
J Nucl Med; 1994 Oct; 35(10):1662-4. PubMed ID: 7931669
[TBL] [Abstract][Full Text] [Related]
20. Severe hypocalcaemia associated with extensive osteoblastic metastases in a patient with prostate cancer.
Fokkema MI; de Heide LJ; van Schelven WD; Hamdy NA
Neth J Med; 2005 Jan; 63(1):34-7. PubMed ID: 15719851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
